Article Details

Aclaris Secures Global Rights to Promising Atopic Dermatitis Treatment in Biosion Deal

Retrieved on: 2024-11-18 13:17:04

Tags for this article:

Click the tags to see associated articles and topics

Aclaris Secures Global Rights to Promising Atopic Dermatitis Treatment in Biosion Deal. View article details on hiswai:

Excerpt

... monoclonal antibody, and BSI-502, a pre-clinical stage bispecific antibody targeting TSLP and IL4R. BSI-045B has shown promising results in a ...

Article found on: www.stocktitan.net

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up